NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Sep. 30, 2013

Summary Of Significant Accounting Policies Tables

Schedule of Fair Value of Financial Instruments

Assets and liabilities measured at fair value on a recurring basis at September 30, 2013

Level 1

Level 2

Level 3

Total
Carrying
Value

Stock warrant derivative liabilities

Assets and liabilities measured at fair value on a recurring basis at September 30, 2012:	Level 1	Level 2	Level 3		Total Carrying Value
Stock warrant derivative liabilities	$	$	$	768,696	$	768,696
	$	$	$	768,696	$	768,696

Schedule of Fair Value of Financial Instruments - Level 3 Reconciliation

Level 3 Reconciliation:	Stock Warrant Derivative
Level 3 assets and liabilities at September 30, 2012	$	768,696
Purchases, sales, issuances and settlements (net)		(1,886,338	)
Mark to market adjustments		1,117,642
Total level 3 assets and liabilities at September 30, 2013	$

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References + Details